Shares in Remote Monitored Systems (RMS) jumped after confirming that it will distribute an MHRA-approved mask in India that is proven to kill COVID-19 and other influenza viruses.

The firm explained that its Pro-Larva mask is clinically proven to kill 99% of COVID-19 and influenza viruses within five minutes of contact and continues to kill the virus for seven hours. 

The Company, which reiterated this morning’s news to investors as confirmed by the British High Commission, outlined that this is the first ever antiviral mask to be approved by the U.K.'s Medicines and Healthcare products Regulatory Agency as a Class 1 medical device.

As outlined by the British High Commission, this new Anglo-Indian partnership has been formed between British technology firm Pharm 2 Farm, a subsidiary of nanosynth group (the name of which RMS is due to assume this coming Monday) and India's VKE Enterprises. 

Speaking on the new distribution partnership this morning, the British High Commission stated: “This important healthcare partnership introduces affordable technology that will help protect the Indian population, saving lives and supporting a developing healthcare market.”

Shares in Remote Monitored Systems were trading 29.17% at 0.775p following the news.

British inventor, Dr Gareth Cave, Founder of Pharm 2 Farm and Director of nanosynth, explained: "The mask we've developed has been proven to inactivate viruses upon contact; the antiviral layer kills virus which has been blocked by the filter layers. The challenge with conventional surgical-type masks is that they only block viruses from entering or exiting the mask. They don't have an active mechanism for killing it once it's trapped in the mask.”

He added, "Our new antiviral mask has been designed to utilise the existing barrier technology and combine it with our nanotechnology to kill the virus once it is trapped there.
 
"We've added the barrier layer to both sides of the mask so not only does it protect the wearer but also those around. By killing the virus on contact, it also means that the used face mask can be safely disposed of and not be a potential source of passive transfer."

Vivek Kohli, Chairman of VKE Enterprises said the introduction of the distribution agreement represents an “exciting opportunity for a new Anglo-Indian partnership to do good in India.”
 
Graeme Todd- Business Development Manager at Pro-Larva commented: "With the initial negative impact Covid-19 had on India we were determined to make a difference with our technology. VKE Enterprises have stood out and we are proud to be working with them." 

Follow News & Updates from Remote Monitored Systems: